Current Appointments & Affiliations
Professor of Neurology
·
2025 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
Chronic Inflammatory Demyelinating Polyneuropathy: How Pathophysiology Can Guide Treatment.
Journal Article Muscle Nerve · May 20, 2025 Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune demyelinating neuropathy that is most commonly characterized clinically by progressive proximal and distal weakness affecting the upper and lower extremities, sensory loss, and reduc ... Full text Link to item CiteSerum fibrinogen is not elevated in patients with myasthenia gravis.
Journal Article Sci Rep · April 15, 2025 Myasthenia gravis (MG) is an autoimmune, autoantibody-mediated disease characterized by fatigable weakness of skeletal muscles. MG is a heterogeneous disease that currently lacks a robust biomarker for diagnosing all subtypes. Residual serum fibrinogen was ... Full text Open Access Link to item CiteInflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy.
Journal Article BMC Neurol · October 25, 2024 BACKGROUND: INCbase is an international, multicenter prospective observational study using a customizable web-based modular registry to study the clinical, biological and electrophysiological variation and boundaries of chronic inflammatory demyelinating p ... Full text Link to item CiteRecent Grants
: A Phase 3, Single-Arm, Multi-Dose, Pharmacokinetic Comparability Trial between TAK-881 and HYQVIA in Adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical TrialPrincipal Investigator · Awarded by Takeda Development Center Americas, Inc · 2025 - 2028Inflammatory Neuropathy Consortium data Base (INCBase): A prospective international CIDP registry
ResearchPrincipal Investigator · Awarded by University of Minnesota · 2022 - 2026Open Label Extension study of Rozanolixizumab in CIDP
Clinical TrialPrincipal Investigator · Awarded by UCB Biopharma SPRL · 2020 - 2022View All Grants
Education, Training & Certifications
University of North Carolina, Chapel Hill ·
2009
M.D.